Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Kristin Ancell

Hematology | Oncology
Vanderbilt Health Clinicians, LLC
3601 The Vanderbilt Clinic, 
Nashville, TN 
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
Vanderbilt Health Clinicians, LLC
3601 The Vanderbilt Clinic, 
Nashville, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kristin Ancell is a Hematologist and an Oncologist in Nashville, Tennessee. Dr. Ancell is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Melanoma, Neuroendocrine Tumor, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Gastrostomy.

Her clinical research consists of co-authoring 14 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in TN
Hospital Affiliations
Vanderbilt Wilson County Hospital
Vanderbilt University Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

VANDERBILT HEALTH CLINICIANS, LLC
3601 The Vanderbilt Clinic, Nashville, TN 37232
Call: 615-322-3000

Additional Areas of Focus

Dr. Ancell has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Dabrafenib Mesylate, Ipilimumab, Nivolumab, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 3
A Phase 2 Study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma
A Phase 2 Study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: September 10, 2025
Intervention Type: Other, Drug
Study Drug: Vorinostat
Study Phase: Phase 2
A Randomized Two-Arm Phase II Study of Trametinib Alone and in Combination With GSK2141795 in Patients With Advanced Uveal Melanoma
A Randomized Two-Arm Phase II Study of Trametinib Alone and in Combination With GSK2141795 in Patients With Advanced Uveal Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2025
Intervention Type: Drug, Other
Study Phase: Phase 2
View 2 Less Clinical Trials

14 Total Publications

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.
The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.
Journal: Cancers
Published: June 21, 2022
View All 14 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Brian I. Rini
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Brian I. Rini
Hematology Oncology | Hematology | Oncology

Vanderbilt Health Clinicians, LLC

3601 The Vanderbilt Clinic, 
Nashville, TN 
 (0.1 miles away)
615-322-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian Rini is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Rini is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Prostatectomy. Dr. Rini is currently accepting new patients.

Kathryn E. Beckermann
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kathryn E. Beckermann
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kathryn E. Beckermann
Hematology Oncology | Hematology | Oncology

Tennessee Oncology PLLC

4488 Carothers Pkwy, Suite 300, 
Franklin, TN 
 (15.4 miles away)
615-591-4764
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kathryn Beckermann is a Hematologist Oncology specialist and a Hematologist in Franklin, Tennessee. Dr. Beckermann is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, and Adult Soft Tissue Sarcoma. Dr. Beckermann is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Nancy B. Davis
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Nancy B. Davis
Oncology
3601 The Vanderbilt Clinic, 
Nashville, TN 
 (0.1 miles away)
615-936-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Nancy Davis is an Oncologist in Nashville, Tennessee. Dr. Davis is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Adult Soft Tissue Sarcoma, WT1-Related Wilms Tumor Syndromes, and Liver Embolization. Dr. Davis is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ancell's expertise for a condition
ConditionClose
    • Distinguished
    • Chromophobe Renal Cell Carcinoma
      Dr. Ancell is
      Distinguished
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Clear Cell Sarcoma
      Dr. Ancell is
      Distinguished
      . Learn about Clear Cell Sarcoma.
      See more Clear Cell Sarcoma experts
    • Melanoma
      Dr. Ancell is
      Distinguished
      . Learn about Melanoma.
      See more Melanoma experts
    • Muscle Invasive Bladder Cancer
      Dr. Ancell is
      Distinguished
      . Learn about Muscle Invasive Bladder Cancer.
      See more Muscle Invasive Bladder Cancer experts
    • Neuroendocrine Tumor
      Dr. Ancell is
      Distinguished
      . Learn about Neuroendocrine Tumor.
      See more Neuroendocrine Tumor experts
    • Non-Muscle Invasive Bladder Cancer
      Dr. Ancell is
      Distinguished
      . Learn about Non-Muscle Invasive Bladder Cancer.
      See more Non-Muscle Invasive Bladder Cancer experts
    View All 7 Distinguished Conditions
    • Advanced
    • Adult Soft Tissue Sarcoma
      Dr. Ancell is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Ancell is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Bladder Cancer
      Dr. Ancell is
      Advanced
      . Learn about Bladder Cancer.
      See more Bladder Cancer experts
    • EGFR Positive Lung Cancer
      Dr. Ancell is
      Advanced
      . Learn about EGFR Positive Lung Cancer.
      See more EGFR Positive Lung Cancer experts
    • Familial Prostate Cancer
      Dr. Ancell is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Familial Wilms Tumor 2
      Dr. Ancell is
      Advanced
      . Learn about Familial Wilms Tumor 2.
      See more Familial Wilms Tumor 2 experts
    View All 19 Advanced Conditions
    • Experienced
    • Adrenal Cancer
      Dr. Ancell is
      Experienced
      . Learn about Adrenal Cancer.
      See more Adrenal Cancer experts
    • Anal Cancer
      Dr. Ancell is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Appendix Cancer
      Dr. Ancell is
      Experienced
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    • Bone Tumor
      Dr. Ancell is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Carcinoid Syndrome
      Dr. Ancell is
      Experienced
      . Learn about Carcinoid Syndrome.
      See more Carcinoid Syndrome experts
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Ancell is
      Experienced
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    View All 41 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved